In the future, the definition of HER2 status in BC will comprise a three-step approach including i) HER2 positive, ii) HER2-negative, and iii) HER2-low breast carcinomas, with the latter potentially benefiting from targeted treatment options. Here, ERBB2 is linked to breast cancer.